HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations

Research output: Contribution to journalReview article

Abstract

Hypoxia occurs frequently in human cancers and induces adaptive changes in cell metabolism that include a switch from oxidative phosphorylation to glycolysis, increased glycogen synthesis, and a switch from glucose to glutamine as the major substrate for fatty acid synthesis. This broad metabolic reprogramming is coordinated at the transcriptional level by HIF-1, which functions as a master regulator to balance oxygen supply and demand. HIF-1 is also activated in cancer cells by tumor suppressor (e.g., VHL) loss of function and oncogene gain of function (leading to PI3K/AKT/mTOR activity) and mediates metabolic alterations that drive cancer progression and resistance to therapy. Inhibitors of HIF-1 or metabolic enzymes may impair the metabolic flexibility of cancer cells and make them more sensitive to anticancer drugs.

Original languageEnglish (US)
Pages (from-to)3664-3671
Number of pages8
JournalJournal of Clinical Investigation
Volume123
Issue number9
DOIs
StatePublished - Sep 3 2013

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations'. Together they form a unique fingerprint.

  • Cite this